Bigul

Medico Intercontinental Ltd - 539938 - Intimation Of The Book Closure & Annual General Meeting

We are pleased to inform you that the meeting of Board of Directors was held on 29th May, 2023, wherein the Board decided to convene the Annual General Meeting of the Company on Friday, 30th June, 2023 at 12:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, please be informed that the Register of Transfer and Register of Members of the Company shall remain closed as per the dates mentioned in the attached file for the purpose of conducting AGM.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Record Date For Final Dividend - June 23, 2023

The Record Date has been fixed as Friday, June 23, 2023 to determine the list of members entitled to receive the Final Dividend for the financial year 2022-23, recommended by the Board of Directors subject to the approval of the same by the members at the ensuing Annual General Meeting.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Corporate Action-Board approves Dividend

Board Recommended a final dividend of Rs. 0.10/- per equity share of the face value of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval by the shareholders at their 39th Annual General Meeting. The Dividend, if approved by the Shareholders will be paid on or after 5th July, 2023.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Related Party Transactions Report For The Half Year Ended 31St March 2023

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the details of Related Party Transactions for the half year ended on March 31, 2023 in the format prescribed by SEBI.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Change in Directorate

Reappointment of Managing Director and Independent Director of the Company.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Change in Management

Reappointment of Managing Directors and Independent Director of the Company.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Results - Financial Year Ended 31St March, 2023

Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 29, 2023, based on the recommendations of Audit Committee and Nomination and Remuneration Committee, inter alia, considered and approved items as per the attached file.
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30, 33 And 42 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 29, 2023, based on the recommendations of Audit Committee and Nomination and Remuneration Committee, inter alia, considered and approved various items as per attached file
29-05-2023
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March, 2023 and Recommend dividend, if any, for the financial year ended 31st March, 2023 and any other business items as per agenda circulated. Further, in continuation of our earlier intimation dated March 31, 2023, in compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations and in pursuant to Companies Code of Conduct for prevention of Insider Trading in Shares of the Company, the Trading window for dealing in the securities of the Company for all the designated persons including insiders has already been closed w.e.f 31st March, 2023 and the same shall be closed till the conclusion of 48 hours after the declaration of financial results of the company for the quarter and year ended March 31, 2023.
22-05-2023
Next Page
Close

Let's Open Free Demat Account